Annual EBIT
-$69.49 M
+$23.13 M+24.97%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual earnings before interest & taxes is -$69.49 million, with the most recent change of +$23.13 million (+24.97%) on December 31, 2023.
- During the last 3 years, EIGR annual EBIT has fallen by -$8.03 million (-13.07%).
- EIGR annual EBIT is now -3099.40% below its all-time high of -$2.17 million, reached on December 1, 2011.
Performance
EIGR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$12.03 M
+$4.59 M+27.63%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly earnings before interest & taxes is -$12.03 million, with the most recent change of +$4.59 million (+27.63%) on December 31, 2023.
- Over the past year, EIGR quarterly EBIT has increased by +$11.89 million (+49.73%).
- EIGR quarterly EBIT is now -139.88% below its all-time high of $30.15 million, reached on March 31, 2021.
Performance
EIGR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$69.49 M
+$11.89 M+14.62%
December 31, 2023
Summary
- As of February 12, 2025, EIGR TTM earnings before interest & taxes is -$69.49 million, with the most recent change of +$11.89 million (+14.62%) on December 31, 2023.
- Over the past year, EIGR TTM EBIT has increased by +$23.13 million (+24.97%).
- EIGR TTM EBIT is now -2279.83% below its all-time high of -$2.92 million, reached on June 30, 2016.
Performance
EIGR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
EIGR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.0% | +49.7% | +25.0% |
| 3 y3 years | -13.1% | +32.8% | -13.1% |
| 5 y5 years | -38.8% | +23.6% | -4.0% |
EIGR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -129.4% | +25.0% | at high | +53.8% | -129.4% | +25.0% |
| 5 y | 5-year | -129.4% | +25.0% | -139.9% | +53.8% | -310.0% | +25.0% |
| alltime | all time | -3099.4% | +25.0% | -139.9% | +53.8% | -2279.8% | +25.0% |
Eiger BioPharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$69.49 M(-25.0%) | -$12.03 M(-27.6%) | -$69.49 M(-14.6%) |
| Sep 2023 | - | -$16.62 M(-14.1%) | -$81.39 M(-10.4%) |
| Jun 2023 | - | -$19.35 M(-10.0%) | -$90.79 M(-1.7%) |
| Mar 2023 | - | -$21.50 M(-10.1%) | -$92.37 M(-0.3%) |
| Dec 2022 | -$92.62 M(+205.7%) | -$23.92 M(-8.1%) | -$92.62 M(+3.4%) |
| Sep 2022 | - | -$26.02 M(+24.3%) | -$89.55 M(+5.5%) |
| Jun 2022 | - | -$20.93 M(-3.7%) | -$84.84 M(+3.2%) |
| Mar 2022 | - | -$21.75 M(+4.3%) | -$82.19 M(+171.3%) |
| Dec 2021 | -$30.29 M(-50.7%) | -$20.85 M(-2.2%) | -$30.29 M(+10.8%) |
| Sep 2021 | - | -$21.31 M(+16.6%) | -$27.34 M(+31.4%) |
| Jun 2021 | - | -$18.28 M(-160.6%) | -$20.80 M(+22.7%) |
| Mar 2021 | - | $30.15 M(-268.5%) | -$16.95 M(-72.4%) |
| Dec 2020 | -$61.46 M(-8.1%) | -$17.89 M(+21.1%) | -$61.46 M(+3.1%) |
| Sep 2020 | - | -$14.77 M(+2.3%) | -$59.60 M(-4.7%) |
| Jun 2020 | - | -$14.44 M(+0.6%) | -$62.55 M(-3.4%) |
| Mar 2020 | - | -$14.36 M(-10.5%) | -$64.78 M(-3.1%) |
| Dec 2019 | -$66.85 M(+33.5%) | -$16.03 M(-9.6%) | -$66.85 M(+0.4%) |
| Sep 2019 | - | -$17.73 M(+6.4%) | -$66.56 M(+1.9%) |
| Jun 2019 | - | -$16.66 M(+1.4%) | -$65.29 M(+12.5%) |
| Mar 2019 | - | -$16.42 M(+4.3%) | -$58.05 M(+16.0%) |
| Dec 2018 | -$50.06 M | -$15.75 M(-4.4%) | -$50.06 M(+11.7%) |
| Sep 2018 | - | -$16.46 M(+74.8%) | -$44.81 M(+20.7%) |
| Jun 2018 | - | -$9.42 M(+11.7%) | -$37.13 M(-3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$8.43 M(-19.7%) | -$38.48 M(-6.0%) |
| Dec 2017 | -$40.92 M(-11.8%) | -$10.50 M(+19.5%) | -$40.92 M(-5.2%) |
| Sep 2017 | - | -$8.78 M(-18.4%) | -$43.19 M(-5.7%) |
| Jun 2017 | - | -$10.77 M(-1.0%) | -$45.78 M(-5.0%) |
| Mar 2017 | - | -$10.88 M(-14.8%) | -$48.21 M(+3.9%) |
| Dec 2016 | -$46.40 M(+257.7%) | -$12.76 M(+12.3%) | -$46.40 M(+402.1%) |
| Sep 2016 | - | -$11.37 M(-13.9%) | -$9.24 M(+216.5%) |
| Jun 2016 | - | -$13.20 M(+45.7%) | -$2.92 M(-49.6%) |
| Mar 2016 | - | -$9.06 M(-137.2%) | -$5.80 M(-55.3%) |
| Dec 2015 | -$12.97 M(-60.8%) | $24.39 M(-583.1%) | -$12.97 M(-73.1%) |
| Sep 2015 | - | -$5.05 M(-68.6%) | -$48.30 M(-5.9%) |
| Jun 2015 | - | -$16.08 M(-1.0%) | -$51.33 M(+21.5%) |
| Mar 2015 | - | -$16.24 M(+48.5%) | -$42.24 M(+27.6%) |
| Dec 2014 | -$33.11 M(+65.3%) | -$10.93 M(+35.2%) | -$33.11 M(+17.0%) |
| Sep 2014 | - | -$8.09 M(+15.7%) | -$28.30 M(+10.3%) |
| Jun 2014 | - | -$6.99 M(-1.6%) | -$25.67 M(+8.7%) |
| Mar 2014 | - | -$7.10 M(+16.1%) | -$23.61 M(+17.8%) |
| Dec 2013 | -$20.03 M(+27.1%) | -$6.12 M(+12.2%) | -$20.03 M(+44.0%) |
| Sep 2013 | - | -$5.45 M(+10.6%) | -$13.91 M(+64.5%) |
| Jun 2013 | - | -$4.93 M(+39.6%) | -$8.46 M(+139.6%) |
| Mar 2013 | - | -$3.53 M | -$3.53 M |
| Dec 2012 | -$15.76 M(+625.7%) | - | - |
| Dec 2011 | -$2.17 M(-63.0%) | - | - |
| Jun 2011 | -$5.87 M | - | - |
FAQ
- What is Eiger BioPharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual EBIT year-on-year change?
- What is Eiger BioPharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly EBIT year-on-year change?
- What is Eiger BioPharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals TTM EBIT year-on-year change?
What is Eiger BioPharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of EIGR is -$69.49 M
What is the all time high annual EBIT for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual earnings before interest & taxes is -$2.17 M
What is Eiger BioPharmaceuticals annual EBIT year-on-year change?
Over the past year, EIGR annual earnings before interest & taxes has changed by +$23.13 M (+24.97%)
What is Eiger BioPharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of EIGR is -$12.03 M
What is the all time high quarterly EBIT for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly earnings before interest & taxes is $30.15 M
What is Eiger BioPharmaceuticals quarterly EBIT year-on-year change?
Over the past year, EIGR quarterly earnings before interest & taxes has changed by +$11.89 M (+49.73%)
What is Eiger BioPharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of EIGR is -$69.49 M
What is the all time high TTM EBIT for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high TTM earnings before interest & taxes is -$2.92 M
What is Eiger BioPharmaceuticals TTM EBIT year-on-year change?
Over the past year, EIGR TTM earnings before interest & taxes has changed by +$23.13 M (+24.97%)